Non-Steroidal Anti-inflammatory Drugs Market Revenue Anticipated to Reach $29.96 Billion by 2030 at 6.5% CAGR
The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Market Size Of The Non-Steroidal Anti-inflammatory Drugs Market In 2026 And What Value Is Projected For 2030?
The non-steroidal anti-inflammatory drugs market has experienced significant expansion in recent years. It is anticipated to increase from $21.89 billion in 2025 to $23.31 billion in 2026, registering a compound annual growth rate (CAGR) of 6.5%. This historical growth can be ascribed to factors including the escalating prevalence of arthritis and musculoskeletal disorders, enhanced understanding of pain management therapies, the expansion of the geriatric population, the proliferation of retail pharmacies, and innovations in drug formulation technologies.
The market for non-steroidal anti-inflammatory drugs is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $29.96 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.5%. Factors contributing to this growth during the forecast period include the increasing adoption of personalized medicine, the expansion of e-pharmacy platforms, heightened research and development efforts into innovative NSAID formulations, the growing prevalence of chronic inflammatory diseases, and the incorporation of digital health solutions for monitoring pain. Key trends anticipated during this period encompass personalized approaches to pain management, an increasing consumer demand for over-the-counter anti-inflammatory drugs, the creation of fast-acting formulations, a concentrated focus on managing chronic pain and arthritis, and the broadening of online pharmacy channels.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8023&type=smp
Which Growth Drivers Are Contributing To The Progress Of The Non-Steroidal Anti-inflammatory Drugs Market?
The increasing prevalence of musculoskeletal disorders (MSDs) is anticipated to propel the growth of the non-steroidal anti-inflammatory drug market. MSDs are a wide range of conditions affecting the musculoskeletal system, including muscles, bones, tendons, ligaments, and joints. Non-steroidal anti-inflammatory drugs (NSAIDs) are crucial for managing the pain and inflammation associated with ailments like arthritis, osteoarthritis, and rheumatoid arthritis. Contributing factors to this market expansion include an aging population, enhanced awareness and diagnosis of musculoskeletal disorders, orthopedic procedures, sports injuries, and the chronic nature of these conditions. For instance, according to GOV.UK in January 2024, 18.4% of individuals aged 16 and older in 2023 reported a long-term musculoskeletal (MSK) condition, showing an increase from the 17.6% prevalence noted in 2022. Therefore, the rising incidence of musculoskeletal disorders is driving the demand within the non-steroidal anti-inflammatory drugs market.
What Are The Key Segments Of The Non-Steroidal Anti-inflammatory Drugs Market?
The non-steroidal anti-inflammatory drugs market covered in this report is segmented –
1) By Route Of Administration: Oral, Topical, Other Route Of Administration
2) By Disease Indication: Arthritis, Migraine, Ophthalmic Diseases, Other Disease Indications
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
Subsegments:
1) By Oral: Tablets, Capsules, Liquids Or Solutions
2) By Topical: Gels, Creams, Patches
3) By Other Route Of Administration: Injectable (Intravenous And Intramuscular), Suppositories
What Key Trends Are Influencing The Development Of The Non-Steroidal Anti-inflammatory Drugs Market?
Major companies operating in the non-steroidal anti-inflammatory drugs (NSAIDs) market are concentrating on creating innovative solutions, including combination analgesic–gastroprotective formulations. This effort is driven by the increasing demand for effective pain management coupled with a reduction in gastrointestinal risks commonly associated with long-term NSAID usage. These dual-action technologies merge an NSAID with a protective agent to maintain anti-inflammatory efficacy while preventing stomach irritation, thus offering a more secure alternative to traditional single-agent NSAIDs. For instance, in March 2024, Endo International plc, an Ireland-based pharmaceutical company, launched ibuprofen-famotidine 800 mg/26.6 mg tablets, an advanced product that combines the analgesic and anti-inflammatory effects of ibuprofen with the gastroprotective action of famotidine. This tablet is specifically designed to alleviate pain while minimizing gastrointestinal side effects like ulcers or irritation that frequently accompany prolonged NSAID therapy, thereby enhancing safety and improving patient adherence.
Who Are The Leading Companies Operating In The Non-Steroidal Anti-inflammatory Drugs Market?
Major companies operating in the non-steroidal anti-inflammatory drugs market are Pfizer Inc., Bayer AG, Johnson & Johnson, Sun Pharmaceutical Industries Ltd., Assertio Therapeutics Inc., Iroko Pharmaceuticals Inc., Perrigo Company PLC, Hikma Pharmaceuticals PLC, Glenmark Pharmaceuticals Limited, Aspen Pharmacare Holdings Limited, Sagent Pharmaceuticals Inc., Advanced Pharma Inc., Akorn Operating Company LLC, Alembic Pharmaceuticals Limited, Torrent Pharmaceuticals Limited, Lupin Limited, Cipla Limited, Zydus Cadila Healthcare Limited, Aurobindo Pharma Limited, Sanofi S.A., GlaxoSmithKline PLC, Horizon Therapeutics PLC, Novartis AG, Roche Holding AG, AbbVie Inc., Bristol-Myers Squibb Company
Read the full non-steroidal anti-inflammatory drugs market report here:
What Are The Leading Geographic Regions In The Non-Steroidal Anti-inflammatory Drugs Market?
North America was the largest region in the non-steroidal anti-inflammatory drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the non-steroidal anti-inflammatory drugs market during the forecast period. The regions covered in the non-steroidal anti-inflammatory drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Non-Steroidal Anti-inflammatory Drugs Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=8023&type=smp
Browse Through More Reports Similar to the Global Non-Steroidal Anti-inflammatory Drugs Market 2026, By The Business Research Company
Non Steroidal Anti Inflammatory Drugs Market Report 2026
Anti Inflammatory Therapeutics Market Report 2026
Rheumatoid Arthritis Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/rheumatoid-arthritis-drugs-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
